25 research outputs found

    Taller: Encerrados pero enREDados

    Get PDF
    La exclusiĂłn sociocultural de la vejez genera abandono, invisibilidad, nulidad de derechos y pocas oportunidades para que las personas mayores que habitan en el Área Metropolitana de Guadalajara vivan plenamente esta etapa de sus vidas. El objetivo fue empoderar a las personas mayores que habitan en el AMG, a travĂ©s de talleres de autocuidado (salud fĂ­sica y mental) y del desarrollo de proyectos de diseño colaborativo que generen alternativas que contribuyan a mejorar sus condiciones de vida para que resignifiquen esta etapa de su vida. El trabajo colaborativo a travĂ©s del taller Encerrados pero enREDados permitiĂł por medio de talleres virtuales abonar a la calidad de vida de este grupo poblacional en el contexto por COVID-19 mediante el uso de las aplicaciones de whatsapp y zoom. Se presenta a lo largo de este documento las experiencias de aprendizaje por estudiantes y la contribuciĂłn social que implica el trabajar con personas mayores a partir de un contexto que ha implicado la emergencia sanitaria derivada por la pandemia de COVID 19 que ha llevado el experimentar y continuar en aislamiento social. AĂșn en el contexto en el que se mantiene el confinamiento, a travĂ©s de distintas estrategias de intervenciĂłn que buscaron sumar al bienestar cotidiano de este grupo etario abordando las siguientes temĂĄticas: 1) ResignificaciĂłn de la vejez, 2) NutriciĂłn para personas mayores, 3) Accesibilidad y seguridad en el espacio pĂșblico y privado, 4) Red de apoyo para la productividad en la vejez, 5) Accesibilidad y seguridad en el espacio pĂșblico y privado, 6) RegulaciĂłn emocional, 7) Accesibilidad y seguridad en el espacio pĂșblico, 7) Red de apoyo para la productividad en la vejez, 9) Accesibilidad y seguridad en el espacio pĂșblico y privado y 10) RegulaciĂłn emocional en las que han participado adultos mayores inmersos dentro Sistema DIF en distintos municipios: Guadalajara, Zapopan,Tlaquepaque y Tlajomulco.ITESO, A.C

    The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Get PDF
    Background: Mortality due to COVID-19 is high, especially in patients requiring mechanical ventilation. The purpose of the study is to investigate associations between mortality and variables measured during the first three days of mechanical ventilation in patients with COVID-19 intubated at ICU admission. Methods: Multicenter, observational, cohort study includes consecutive patients with COVID-19 admitted to 44 Spanish ICUs between February 25 and July 31, 2020, who required intubation at ICU admission and mechanical ventilation for more than three days. We collected demographic and clinical data prior to admission; information about clinical evolution at days 1 and 3 of mechanical ventilation; and outcomes. Results: Of the 2,095 patients with COVID-19 admitted to the ICU, 1,118 (53.3%) were intubated at day 1 and remained under mechanical ventilation at day three. From days 1 to 3, PaO2/FiO2 increased from 115.6 [80.0-171.2] to 180.0 [135.4-227.9] mmHg and the ventilatory ratio from 1.73 [1.33-2.25] to 1.96 [1.61-2.40]. In-hospital mortality was 38.7%. A higher increase between ICU admission and day 3 in the ventilatory ratio (OR 1.04 [CI 1.01-1.07], p = 0.030) and creatinine levels (OR 1.05 [CI 1.01-1.09], p = 0.005) and a lower increase in platelet counts (OR 0.96 [CI 0.93-1.00], p = 0.037) were independently associated with a higher risk of death. No association between mortality and the PaO2/FiO2 variation was observed (OR 0.99 [CI 0.95 to 1.02], p = 0.47). Conclusions: Higher ventilatory ratio and its increase at day 3 is associated with mortality in patients with COVID-19 receiving mechanical ventilation at ICU admission. No association was found in the PaO2/FiO2 variation

    Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

    Get PDF
    Few treatments with a distinct mechanism of action are available for patients with platinum-refractory advanced or metastatic urothelial carcinoma. We assessed the efficacy and safety of treatment with docetaxel plus either ramucirumab-a human IgG1 VEGFR-2 antagonist-or placebo in this patient population

    Centrality evolution of the charged-particle pseudorapidity density over a broad pseudorapidity range in Pb-Pb collisions at root s(NN)=2.76TeV

    Get PDF
    Peer reviewe

    Imputation performance in Latin American populations: improving rare variants representation with the inclusion of native American genomes

    No full text
    Current Genome-Wide Association Studies (GWAS) rely on genotype imputation to increase statistical power, improve fine-mapping of association signals, and facilitate meta-analyses. Due to the complex demographic history of Latin America and the lack of balanced representation of Native American genomes in current imputation panels, the discovery of locally relevant disease variants is likely to be missed, limiting the scope and impact of biomedical research in these populations. Therefore, the necessity of better diversity representation in genomic databases is a scientific imperative. Here, we expand the 1,000 Genomes reference panel (1KGP) with 134 Native American genomes (1KGP + NAT) to assess imputation performance in Latin American individuals of mixed ancestry. Our panel increased the number of SNPs above the GWAS quality threshold, thus improving statistical power for association studies in the region. It also increased imputation accuracy, particularly in low-frequency variants segregating in Native American ancestry tracts. The improvement is subtle but consistent across countries and proportional to the number of genomes added from local source populations. To project the potential improvement with a higher number of reference genomes, we performed simulations and found that at least 3,000 Native American genomes are needed to equal the imputation performance of variants in European ancestry tracts. This reflects the concerning imbalance of diversity in current references and highlights the contribution of our work to reducing it while complementing efforts to improve global equity in genomic research.Published versionThis work was supported by “The Mexican Biobank Project: Building Capacity for Big Data Science in Medical Genomics in Admixed Populations”, a binational initiative between Mexico and the UK co-funded by CONACYT (Grant number FONCICYT/50/ 2016), and The Newton Fund through The Medical Research Council (Grant number MR/N028937/1) awarded to AME and AVSH. It was also supported by the International Center for Genetic Engineering and Biotechnology (ICGEB, Italy) grant number CRP/MEX20-01. MS was partially supported by the Chicago Fellows program of the University of Chicago. DODV is supported by the UC MEXUS CONACYT collaborative program (Grant number CN-19-29), and the UNAM PAPIIT funding program (Grant number IA200620)

    Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    Get PDF
    Objectives: This study aimed to assess the real use of cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) in the Spanish National Endocarditis Database (GAMES) and to compare it with antistaphylococcal penicillin (ASP). Methods: Prospective cohort study with retrospective analysis of a cohort of MSSA IE treated with cloxacillin and/or cefazolin. Outcomes assessed were relapse; intra-hospital, overall, and endocarditis-related mortality; and adverse events. Risk of renal toxicity with each treatment was evaluated separately. Results: We included 631 IE episodes caused by MSSA treated with cloxacillin and/or cefazolin. Antibiotic treatment was cloxacillin, cefazolin, or both in 537 (85%), 57 (9%), and 37 (6%) episodes, respectively. Patients treated with cefazolin had significantly higher rates of comorbidities (median Charlson Index 7, P <0.01) and previous renal failure (57.9%, P <0.01). Patients treated with cloxacillin presented higher rates of septic shock (25%, P = 0.033) and new-onset or worsening renal failure (47.3%, P = 0.024) with significantly higher rates of in-hospital mortality (38.5%, P = 0.017). One-year IE-related mortality and rate of relapses were similar between treatment groups. None of the treatments were identified as risk or protective factors. Conclusion: Our results suggest that cefazolin is a valuable option for the treatment of MSSA IE, without differences in 1-year mortality or relapses compared with cloxacillin, and might be considered equally effective

    Transverse momentum spectra of charged particles in proton–proton collisions at √s=900 GeV with ALICE at the LHC

    No full text
    The inclusive charged particle transverse momentum distribution is measured in proton–proton collisions at s=900 GeV at the LHC using the ALICE detector. The measurement is performed in the central pseudorapidity region (|η|<0.8) over the transverse momentum range 0.15<pT<10 GeV/c. The correlation between transverse momentum and particle multiplicity is also studied. Results are presented for inelastic (INEL) and non-single-diffractive (NSD) events. The average transverse momentum for |η|<0.8 is 〈pT〉INEL=0.483±0.001 (stat.)±0.007 (syst.) GeV/c and 〈pT〉NSD=0.489±0.001 (stat.)±0.007 (syst.) GeV/c, respectively. The data exhibit a slightly larger 〈pT〉 than measurements in wider pseudorapidity intervals. The results are compared to simulations with the Monte Carlo event generators PYTHIA and PHOJET

    Production of charged pions, kaons and protons at large transverse momenta in pp and Pb–Pb collisions at √sNN = 2.76 TeV

    No full text
    Transverse momentum spectra of π±, K± and p(pÂŻ) up to pT = 20 GeV/c at mid-rapidity in pp, peripheral (60–80%) and central (0–5%) Pb–Pb collisions at √sNN = 2.76 TeV have been measured using the ALICE detector at the Large Hadron Collider. The proton-to-pion and the kaon-to-pion ratios both show a distinct peak at pT ≈ 3 GeV/c in central Pb–Pb collisions. Below the peak, pT 10 GeV/c particle ratios in pp and Pb–Pb collisions are in agreement and the nuclear modification factors for π±, K± and p(pÂŻ) indicate that, within the systematic and statistical uncertainties, the suppression is the same. This suggests that the chemical composition of leading particles from jets in the medium is similar to that of vacuum jets
    corecore